Difference between revisions of "Team:Cardiff Wales/silverfulfilment"

 
(10 intermediate revisions by 2 users not shown)
Line 4: Line 4:
 
<html>  
 
<html>  
 
<body>  
 
<body>  
 
+
<div class="column_full_size"/>
 
<center> <h1><br><br><br>Accomplishing Silver Medal Criteria <br><br><br></h1> </center>  
 
<center> <h1><br><br><br>Accomplishing Silver Medal Criteria <br><br><br></h1> </center>  
  
 
<center>
 
<center>
<table>
 
  <tr>
 
    <th style="background-color:#999999; color:black;">Silver</th>
 
    <th style="background-color:#999999; color:black;" colspan="3">All criteria must be met</th>
 
  </tr>
 
  <tr>
 
    <td  style="background-color:#8c8c8c; color:black;">1</td>
 
    <td  style="color:black;">Validated Part/Validated Contribution</td>
 
  <td style="color:black;" >New biobrick</td>
 
<td style="color:black;" >Part function</td>
 
  </tr>
 
  <tr>
 
    <td  style="background-color:#8c8c8c; color:black;">2</td>
 
    <td  style="color:black;">Collaboration</td>
 
<td style="color:black;" colspan="2">Worked with another iGEM team</td>
 
  
  </tr>
 
  <tr>
 
    <td  style="background-color:#8c8c8c; color:black;">3</td>
 
    <td  style="color:black;">Human Practices</td>
 
  <td style="color:black;" colspan="2">Our extensive human practices</td>
 
  </tr>
 
  
</table>
+
<br>
</center>
+
<br><br><br>
+
  
 
<p><img width=10% src="https://static.igem.org/mediawiki/2016/d/d4/T--Cardiff_Wales--Silver.png"/></p>
 
<p><img width=10% src="https://static.igem.org/mediawiki/2016/d/d4/T--Cardiff_Wales--Silver.png"/></p>
Line 41: Line 18:
  
 
<p><b>1. Collaboration:</b> We have greatly enjoyed interacting with iGEM teams from around the World and we generated an important piece of data for the team from the the  
 
<p><b>1. Collaboration:</b> We have greatly enjoyed interacting with iGEM teams from around the World and we generated an important piece of data for the team from the the  
<a href="https://2017.igem.org/Team:Exeter"> University of Exeter</a>. This is documented on our <a href="https://2017.igem.org/Team:Cardiff_Wales/Collaborations">collaborations</a> page.</p>  
+
<a href="https://2017.igem.org/Team:Exeter"> University of Exeter</a>. In addition we had useful discussions about each others projects with the <a href="https://2017.igem.org/Team:Valencia_UPV">Valencia</a> and <a href="https://2017.igem.org/Team:WashU_StLouis">WashU</a> teams. These interactions are documented on our <a href="https://2017.igem.org/Team:Cardiff_Wales/Collaborations">collaborations</a> page.</p>  
<br>
+
<br><hr>
<p><b>2. Human Practices:</b>We have engaged in many outreach events to publicise the awesome potential of <i>SynBio</i> including University Open days, school and public events. In addition we conducted a survey that assessed public attitudes to the use of genetically modified organisms for food or medicines. These are outlined on our <a href="https://2017.igem.org/Team:Cardiff_Wales/Public_outreach">Public Outreach</a> and Survey (LINK) pages.</p>
+
<p><b>2. Human Practices:</b> We have engaged in a number of <a href="https://2017.igem.org/Team:Cardiff_Wales/Public_outreach">outreach events</a> to publicise the potential of plant synthetic biology. These have included University Open days, school and public events. <br>In addition we conducted a <a href="https://2017.igem.org/Team:Cardiff_Wales/Survey">survey</a> that assessed public attitudes to the use of genetically modified organisms for food or medicine. These are outlined on our <a href="https://2017.igem.org/Team:Cardiff_Wales/Public_outreach">public outreach</a> and <a href="https://2017.igem.org/Team:Cardiff_Wales/Survey">survey</a> pages. We also extensively communicated with professional plant bio-technologists for insight into using plants as a biofactory. This information was incorporated into our <a href="https://2017.igem.org/Team:Cardiff_Wales/Modelling">modelling</a>. </p>
<br>
+
<br><hr>
 
+
<p><b>3. Validated Parts:</b>We have generated a set of biobricks that contain a novel set of plant promotors in the Phytobrick standard. these are outlined on our <a href="https://2017.igem.org/Team:Cardiff_Wales/basicparts">Parts page</a>. We tested these parts by expressing the Thyroid Stimulating Hormone antagonist (TSH) in the tobacco leaf expression system (COMPOSITE PART LINK).
+
 
+
  
 +
<p><b>3. Validated Parts:</b> We have generated a set of biobricks that contain a novel set of plant promotors in the Phytobrick standard. These are outlined on our <a href="https://2017.igem.org/Team:Cardiff_Wales/basicparts">parts page</a>. We tested these parts by expressing the Thyroid Stimulating Hormone antagonist (TSH) in the tobacco leaf expression system. These parts are outlined on our <a href="https://2017.igem.org/Team:Cardiff_Wales/compositeparts">composite parts</a> pages and our attempts to express these proteins are outlined on the <a href="https://2017.igem.org/Team:Cardiff_Wales/results">Results</a> page as well as in our <a href+"https://2017.igem.org/Team:Cardiff_Wales/diary">lab diary</a>.<br>
 +
<br>Due to an unfortunate mix up we did not submit our <a href="https://igem.org/2017_Judging_Form?id=2404">Judging form</a> on time. However the generation of these novel basic and composite parts fulfill the Silver requirement.<br> Please ask any questions about this during the poster sessions.
 +
<br><br><br><br>
 +
</p>
  
 +
</center>
 +
</div>
 
</body>
 
</body>
 
</html>
 
</html>

Latest revision as of 11:36, 31 October 2017




Accomplishing Silver Medal Criteria




Silver

1. Collaboration: We have greatly enjoyed interacting with iGEM teams from around the World and we generated an important piece of data for the team from the the University of Exeter. In addition we had useful discussions about each others projects with the Valencia and WashU teams. These interactions are documented on our collaborations page.



2. Human Practices: We have engaged in a number of outreach events to publicise the potential of plant synthetic biology. These have included University Open days, school and public events.
In addition we conducted a survey that assessed public attitudes to the use of genetically modified organisms for food or medicine. These are outlined on our public outreach and survey pages. We also extensively communicated with professional plant bio-technologists for insight into using plants as a biofactory. This information was incorporated into our modelling.



3. Validated Parts: We have generated a set of biobricks that contain a novel set of plant promotors in the Phytobrick standard. These are outlined on our parts page. We tested these parts by expressing the Thyroid Stimulating Hormone antagonist (TSH) in the tobacco leaf expression system. These parts are outlined on our composite parts pages and our attempts to express these proteins are outlined on the Results page as well as in our lab diary.

Due to an unfortunate mix up we did not submit our Judging form on time. However the generation of these novel basic and composite parts fulfill the Silver requirement.
Please ask any questions about this during the poster sessions.